Mr Shirakawa of Kenporen Calls for New Look at Range of Drugs Eligible for Premium for New Drug Development

Shuji Shirakawa Shuji Shirakawa, executive managing director of the National Federation of Health Insurance Societies (Kenporen) and a representative of bill payers at the Central Social Insurance Medical Council (CSIMC), called for a review of the premium for new drug...read more